BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 20029452)

  • 21. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: part 2--ketanserin displacement.
    Catafau AM; Danus M; Bullich S; Nucci G; Llop J; Abanades S; Cunningham VJ; Eersels JL; Pavia J; Farre M
    J Nucl Med; 2006 Jun; 47(6):929-37. PubMed ID: 16741301
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112.
    Cannon DM; Klaver JM; Peck SA; Rallis-Voak D; Erickson K; Drevets WC
    Neuropsychopharmacology; 2009 Apr; 34(5):1277-87. PubMed ID: 18946469
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regional distribution and behavioral correlates of 5-HT(2A) receptors in Alzheimer's disease with [(18)F]deuteroaltanserin and PET.
    Santhosh L; Estok KM; Vogel RS; Tamagnan GD; Baldwin RM; Mitsis EM; Macavoy MG; Staley JK; van Dyck CH
    Psychiatry Res; 2009 Sep; 173(3):212-7. PubMed ID: 19682865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autoradiographic localization of 5-HT(2A) receptors in the human brain using [(3)H]M100907 and [(11)C]M100907.
    Hall H; Farde L; Halldin C; Lundkvist C; Sedvall G
    Synapse; 2000 Dec; 38(4):421-31. PubMed ID: 11044889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain.
    Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A
    Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Characterization of radioiodinated TISCH: a high-affinity and selective ligand for mapping CNS D1 dopamine receptor.
    Billings JJ; Kung MP; Chumpradit S; Mozley D; Alavi A; Kung HF
    J Neurochem; 1992 Jan; 58(1):227-36. PubMed ID: 1530770
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antagonism at serotonin 5-HT(2A) receptors modulates functional activity of frontohippocampal circuit.
    Gozzi A; Crestan V; Turrini G; Clemens M; Bifone A
    Psychopharmacology (Berl); 2010 Mar; 209(1):37-50. PubMed ID: 20111859
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carbon-11-NNC 112: a radioligand for PET examination of striatal and neocortical D1-dopamine receptors.
    Halldin C; Foged C; Chou YH; Karlsson P; Swahn CG; Sandell J; Sedvall G; Farde L
    J Nucl Med; 1998 Dec; 39(12):2061-8. PubMed ID: 9867142
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines.
    Neumeyer JL; Kula NS; Bergman J; Baldessarini RJ
    Eur J Pharmacol; 2003 Aug; 474(2-3):137-40. PubMed ID: 12921854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A database of [(18)F]-altanserin binding to 5-HT(2A) receptors in normal volunteers: normative data and relationship to physiological and demographic variables.
    Adams KH; Pinborg LH; Svarer C; Hasselbalch SG; Holm S; Haugbøl S; Madsen K; Frøkjaer V; Martiny L; Paulson OB; Knudsen GM
    Neuroimage; 2004 Mar; 21(3):1105-13. PubMed ID: 15006678
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PET studies on dopamine D1 receptors in the human brain with carbon-11-SCH 39166 and carbon-11-NNC 756.
    Laihinen AO; Rinne JO; Ruottinen HM; Någren KA; Lehikoinen PK; Oikonen VJ; Ruotsalainen UH; Rinne UK
    J Nucl Med; 1994 Dec; 35(12):1916-20. PubMed ID: 7989969
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys.
    Tsukada H; Nishiyama S; Fukumoto D; Sato K; Kakiuchi T; Domino EF
    Neuropsychopharmacology; 2005 Oct; 30(10):1861-9. PubMed ID: 15841110
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluorinated benzazepines: 1. Synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors.
    Yang ZY; Perry B; Mukherjee J
    Nucl Med Biol; 1996 Aug; 23(6):793-805. PubMed ID: 8940723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement.
    Papadeas ST; Blake BL; Knapp DJ; Breese GR
    J Neurosci; 2004 Jun; 24(26):5863-76. PubMed ID: 15229233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease.
    Ginovart N; Lundin A; Farde L; Halldin C; Bäckman L; Swahn CG; Pauli S; Sedvall G
    Brain; 1997 Mar; 120 ( Pt 3)():503-14. PubMed ID: 9126061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binding characteristics of the 5-HT2A receptor antagonists altanserin and MDL 100907.
    Kristiansen H; Elfving B; Plenge P; Pinborg LH; Gillings N; Knudsen GM
    Synapse; 2005 Dec; 58(4):249-57. PubMed ID: 16206185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo PET study of 5HT(2A) serotonin and D(2) dopamine dysfunction in drug-naive obsessive-compulsive disorder.
    Perani D; Garibotto V; Gorini A; Moresco RM; Henin M; Panzacchi A; Matarrese M; Carpinelli A; Bellodi L; Fazio F
    Neuroimage; 2008 Aug; 42(1):306-14. PubMed ID: 18511303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 11C- and 76Br-labelled NNC 22-0010, selective dopamine D1 receptor radioligands for PET.
    Foged C; Halldin C; Loc'h C; Mazière B; Karlsson P; Mazière M; Swahn CG; Farde L
    Nucl Med Biol; 1996 Aug; 23(6):837-44. PubMed ID: 8940728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 11C-SCH 39166, a selective ligand for visualization of dopamine-D1 receptor binding in the monkey brain using PET.
    Sedvall G; Farde L; Barnett A; Hall H; Halldin C
    Psychopharmacology (Berl); 1991; 103(2):150-3. PubMed ID: 1674157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine.
    Martinez D; Slifstein M; Narendran R; Foltin RW; Broft A; Hwang DR; Perez A; Abi-Dargham A; Fischman MW; Kleber HD; Laruelle M
    Neuropsychopharmacology; 2009 Jun; 34(7):1774-82. PubMed ID: 19177067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.